149 related articles for article (PubMed ID: 34134073)
1. PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor.
Koga S; Onishi H; Masuda S; Fujimura A; Ichimiya S; Nakayama K; Imaizumi A; Nishiyama K; Kojima M; Miyoshi K; Nakamura K; Umebayashi M; Morisaki T; Nakamura M
Transl Oncol; 2021 Sep; 14(9):101152. PubMed ID: 34134073
[TBL] [Abstract][Full Text] [Related]
2. PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor.
Fujimura A; Nakayama K; Imaizumi A; Kawamoto M; Oyama Y; Ichimiya S; Umebayashi M; Koya N; Morisaki T; Nakagawa T; Onishi H
Cancer Immunol Immunother; 2019 Oct; 68(10):1649-1660. PubMed ID: 31562536
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments.
Masuda S; Onishi H; Iwamoto N; Imaizumi A; Koga S; Nagao S; Sakanashi K; Itoyama S; Fujimura A; Komune N; Kogo R; Umebayashi M; Morisaki T; Nakagawa T
J Immunother; 2024 Apr; 47(3):89-97. PubMed ID: 38297883
[TBL] [Abstract][Full Text] [Related]
4. PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target.
Iwamoto N; Onishi H; Masuda S; Imaizumi A; Sakanashi K; Morisaki S; Nagao S; Koga S; Ozono K; Umebayashi M; Morisaki T; Nakamura M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14619-14630. PubMed ID: 37584709
[TBL] [Abstract][Full Text] [Related]
5. NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytes.
Nakayama K; Onishi H; Fujimura A; Imaizumi A; Kawamoto M; Oyama Y; Ichimiya S; Koga S; Fujimoto Y; Nakashima K; Nakamura M
Cell Immunol; 2020 Dec; 358():104237. PubMed ID: 33137650
[TBL] [Abstract][Full Text] [Related]
6. PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer.
Onishi H; Iwamoto N; Sakanashi K; Koga S; Oyama Y; Yanai K; Nakamura K; Nagai S; Fujimura A; Nakayama K; Ozono K; Yamasaki A
Anticancer Res; 2022 Jun; 42(6):2869-2874. PubMed ID: 35641270
[TBL] [Abstract][Full Text] [Related]
7. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
[TBL] [Abstract][Full Text] [Related]
9. PTPN3 suppresses the proliferation and correlates with favorable prognosis of perihilar cholangiocarcinoma by inhibiting AKT phosphorylation.
Sun R; Chen T; Li M; Liu Z; Qiu B; Li Z; Xu Y; Pan C; Zhang Z
Biomed Pharmacother; 2020 Jan; 121():109583. PubMed ID: 31706106
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-574-5p in gastric cancer cells promotes angiogenesis by targeting protein tyrosine phosphatase non-receptor type 3 (PTPN3).
Zhang S; Zhang R; Xu R; Shang J; He H; Yang Q
Gene; 2020 Apr; 733():144383. PubMed ID: 31972307
[TBL] [Abstract][Full Text] [Related]
11. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
12. Normal TCR signal transduction in mice that lack catalytically active PTPN3 protein tyrosine phosphatase.
Bauler TJ; Hughes ED; Arimura Y; Mustelin T; Saunders TL; King PD
J Immunol; 2007 Mar; 178(6):3680-7. PubMed ID: 17339465
[TBL] [Abstract][Full Text] [Related]
13. TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.
Odate S; Nakamura K; Onishi H; Kojima M; Uchiyama A; Nakano K; Kato M; Tanaka M; Katano M
Lung Cancer; 2013 Mar; 79(3):205-14. PubMed ID: 23312550
[TBL] [Abstract][Full Text] [Related]
14. PTPN3 in cancer: unveiling its immune-mediated impact on prognosis and dysregulated signaling pathways.
Abdel-Maksoud MA; Ullah S; Nadeem A; Khan QUA; Zia MK; Ali S; Zakri AM; Almanaa TN; Alfuraydi AA; Al-Qahtani WH; Hameed Y
Am J Transl Res; 2023; 15(11):6464-6475. PubMed ID: 38074816
[TBL] [Abstract][Full Text] [Related]
15. PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma.
Wu CW; Chen JH; Kao HL; Li AF; Lai CH; Chi CW; Lin WC
Anticancer Res; 2006; 26(2B):1643-9. PubMed ID: 16619586
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hepatitis B viral gene expression by protein-tyrosine phosphatase PTPN3.
Hsu EC; Lin YC; Hung CS; Huang CJ; Lee MY; Yang SC; Ting LP
J Biomed Sci; 2007 Nov; 14(6):731-44. PubMed ID: 17588219
[TBL] [Abstract][Full Text] [Related]
17. Interactions of the protein tyrosine phosphatase PTPN3 with viral and cellular partners through its PDZ domain: insights into structural determinants and phosphatase activity.
Genera M; Colcombet-Cazenave B; Croitoru A; Raynal B; Mechaly A; Caillet J; Haouz A; Wolff N; Caillet-Saguy C
Front Mol Biosci; 2023; 10():1192621. PubMed ID: 37200868
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum to "PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor" [Volume 14, Issue 9, September 2021, 101152].
Koga S; Onishi H; Masuda S; Fujimura A; Ichimiya S; Nakayama K; Imaizumi A; Nishiyama K; Kojima M; Miyoshi K; Nakamura K; Umebayashi M; Morisaki T; Nakamurab M
Transl Oncol; 2022 Mar; 17():101344. PubMed ID: 35042060
[No Abstract] [Full Text] [Related]
19. The FERM and PDZ domain-containing protein tyrosine phosphatases, PTPN4 and PTPN3, are both dispensable for T cell receptor signal transduction.
Bauler TJ; Hendriks WJ; King PD
PLoS One; 2008; 3(12):e4014. PubMed ID: 19107198
[TBL] [Abstract][Full Text] [Related]
20. High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma.
Wang Y; Su Y; Ji Z; Lv Z
Med Sci Monit; 2018 Oct; 24():7556-7562. PubMed ID: 30348936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
